Ask about smoking, not quitting: a chronic disease approach to assessing and treating tobacco use
- PMID: 31474229
- PMCID: PMC6717985
- DOI: 10.1186/s13722-019-0159-z
Ask about smoking, not quitting: a chronic disease approach to assessing and treating tobacco use
Abstract
Tobacco use is a chronic relapsing disease, and remains the leading cause of preventable death in much of the world. Increasingly, tobacco use, chiefly cigarette smoking, is being framed as a chronic disease, with periods of use and periods of abstinence. An implicit component of this conceptualization is that treatment-both counseling and pharmacotherapy-may be needed at various intervals for extended periods of time, perhaps over an individual's lifetime. This would mirror the treatment of other chronic conditions, such as diabetes, hypertension, or hyperlipidemia. Yet, clinical trials of tobacco dependence treatment still generally model outcome measures in terms of cessation, abstinence, or quitting, measured at discrete time points. This reinforces the notion that smoking, or tobacco dependence, is a dichotomous condition, and that one is either "cured," or not. Although the goal of treating tobacco dependence is to ensure long-term abstinence (i.e. "quitting"), this model is discordant with clinical reality, in which of periods of tobacco use are interspersed with periods of abstinence. Hence, the goal of treatment is to lengthen the duration of the latter, while shortening the duration of the former. In the clinical arena, this dichotomous model of tobacco use is reflected in electronic health records, where smoking is generally categorized as current, former, or never. We propose that clinicians move away from the dichotomous categorization of tobacco use, and adopt methods used to categorize the status of other chronic conditions. Specifically, biomarkers such as carbon monoxide, cotinine, and anabasine, measured at regular intervals, can provide clinicians with much clearer, clinically relevant and actionable assessments of current tobacco use by their patients. This can be done without making reference to dichotomous states such as current or former use of tobacco. In psychological terms, one can frame tobacco use in terms of states, attributes in specific situations at discrete moments in time, rather than the more durable traits.
Keywords: Chronic disease; Smoking cessation; Tobacco dependence.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Proactive tobacco treatment and population-level cessation: a pragmatic randomized clinical trial.JAMA Intern Med. 2014 May;174(5):671-7. doi: 10.1001/jamainternmed.2014.177. JAMA Intern Med. 2014. PMID: 24615217 Clinical Trial.
-
An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.Nicotine Tob Res. 2024 Jun 21;26(7):796-805. doi: 10.1093/ntr/ntae005. Nicotine Tob Res. 2024. PMID: 38214037 Free PMC article. Review.
-
The Tobacco Status Project (TSP): Study protocol for a randomized controlled trial of a Facebook smoking cessation intervention for young adults.BMC Public Health. 2015 Sep 15;15:897. doi: 10.1186/s12889-015-2217-0. BMC Public Health. 2015. PMID: 26374203 Free PMC article. Clinical Trial.
-
[Smoking reduction and temporary abstinence: new approaches for smoking cessation].J Mal Vasc. 2003 Dec;28(5):293-300. J Mal Vasc. 2003. PMID: 14978435 Review. French.
-
How do text-messaging smoking cessation interventions confer benefit? A multiple mediation analysis of Text2Quit.Addiction. 2017 Apr;112(4):673-682. doi: 10.1111/add.13685. Epub 2016 Dec 12. Addiction. 2017. PMID: 27943511 Free PMC article.
Cited by
-
Qualitative exploration of longer versus shorter quit attempts among adults using E-Cigarettes for combustible cigarette cessation.Addict Behav. 2023 Aug;143:107710. doi: 10.1016/j.addbeh.2023.107710. Epub 2023 Mar 30. Addict Behav. 2023. PMID: 37015170 Free PMC article.
-
Chronic care treatment for smoking cessation in patients with serious mental illness: a pilot randomized trial.BMC Psychiatry. 2021 Feb 17;21(1):104. doi: 10.1186/s12888-021-03113-5. BMC Psychiatry. 2021. PMID: 33593332 Free PMC article. Clinical Trial.
-
Multimorbidity and tooth loss: data from Chilean National Health Survey 2016-2017.BMC Oral Health. 2024 Nov 20;24(1):1417. doi: 10.1186/s12903-024-05184-8. BMC Oral Health. 2024. PMID: 39567956 Free PMC article.
-
E-cigarette Use in Prisons With Recently Established Smokefree Policies: A Qualitative Interview Study With People in Custody in Scotland.Nicotine Tob Res. 2021 May 24;23(6):939-946. doi: 10.1093/ntr/ntaa271. Nicotine Tob Res. 2021. PMID: 33367804 Free PMC article.
-
The old and familiar meets the new and unknown: patient and clinician perceptions on e-cigarettes for smoking reduction in UK general practice, a qualitative interview study.Addiction. 2022 May;117(5):1427-1437. doi: 10.1111/add.15760. Epub 2021 Dec 23. Addiction. 2022. PMID: 34859526 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical